Model Number 405671 |
Device Problem
Obstruction of Flow (2423)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 05/11/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Date of event.The date received by manufacturer has been used for this field.Suspect products name and strength: bupivacaine (0.75%) with dextrose (8.25%) 2 ml (marcaine).A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Event Description
|
It was reported while using bd spinal anesthesia tray during spinal injections, a few of the products have had a delayed release of marcaine.The following information was provided by the initial reporter: during spinal injections, a few of the products have had a delayed release of marcaine.Resulting in higher doses delivered to the patient than desired.
|
|
Manufacturer Narrative
|
The following fields were updated due to additional information: d10: device available for eval yes.D10: returned to manufacturer on: 18-jul-2022.One sample was provided to our quality team for investigation.Upon visual inspection of the retention sample ampules and fluids it was observed that retention samples were clear and colorless therefore, the reported failure mode was not confirmed.A review of the internal manufacturing device records and raw material history files for the reported lot number 0001460001 was performed and no recorded quality problems or rejections related to this incident were found.
|
|
Event Description
|
It was reported while using bd spinal anesthesia tray during spinal injections, a few of the products have had a delayed release of marcaine.The following information was provided by the initial reporter: during spinal injections, a few of the products have had a delayed release of marcaine.Resulting in higher doses delivered to the patient than desired.
|
|
Search Alerts/Recalls
|